People who stop taking weight-loss injections may face a raised risk of heart attack and stroke, according to The Sun. The Sun reports that two potentially deadly conditions can strike up to two years after treatment ends.
The warning covers drugs including Mounjaro and Wegovy, according to Cheshire Live. ScienceDaily also reports that stopping Ozempic may increase the risk of heart attack and stroke.
The reports focus on what happens when patients discontinue the injections rather than on the drugs themselves. The Sun frames the two conditions as killers that can emerge well after the last dose, though the available material does not specify how the risk was measured or in which patients.
The coverage sits alongside separate reporting on why the drugs stop working for some people. BBC Science Focus Magazine has examined that question and what can be done about it. Psychology Today reports that health behaviors and perceptions play a large part in whether patients stick to their treatment.
Taken together, the reporting points to two distinct issues: the consequences of stopping treatment, and the reasons some patients stop or see results fade in the first place. The available summaries do not include figures, study details or named researchers, so the size of any added risk remains unclear from this material alone.
What to watch next: whether the researchers behind the findings publish full data on how long the elevated risk persists and which patients are most affected.
